Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
07/2003
07/10/2003WO2003055848A2 Urea derivatives as vr1- antagonists
07/10/2003WO2003055847A1 Carboxylic acid derivative
07/10/2003WO2003055525A1 Acid-containing preparations
07/10/2003WO2003055523A1 Pharmaceutical composition comprising an alpha-glucosidase inhibitor and a 4-oxobutanoic acid, and the use thereof for treating diabetes
07/10/2003WO2003055522A1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors
07/10/2003WO2003055521A1 Remedies for mild recognition deflict
07/10/2003WO2003055498A1 Composition comprising dextrinsulfate for the treatment of sexual transmitted diseases (std)
07/10/2003WO2003055492A1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer's disease and conditions associated with glycogen synthase kinase-3
07/10/2003WO2003055491A1 Substituted quinazoline derivatives as inhibitors of aurora kinases
07/10/2003WO2003055488A1 Remedies or preventives for diseases in association with tissue fibrosis
07/10/2003WO2003055484A1 Urea derivatives
07/10/2003WO2003055483A1 Famotidine injection
07/10/2003WO2003055482A1 Amide derivatives as gk activators
07/10/2003WO2003055481A1 Organ fibrosis inhibitors
07/10/2003WO2003055478A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
07/10/2003WO2003055463A1 Composition comprising at least an oxazolin for inhibiting langerhans cell migration, and uses thereof
07/10/2003WO2003055462A2 Composition comprising at least an alkanolamide for inhibiting langerhans cell migration, and uses thereof
07/10/2003WO2003055447A2 Heterocyclic acridone inhibitors of impdh enzyme
07/10/2003WO2003055443A2 Bone morphogenic proteins (bmp), bmp receptors and bmp binding proteins and their use in the diagnosis and treatment of glaucoma
07/10/2003WO2003050119A3 Urea substituted imidazopyridines
07/10/2003WO2003043987A3 (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease
07/10/2003WO2003035670A3 Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis
07/10/2003WO2003035107A8 Enzyme inhibitors for inactivating allergens
07/10/2003WO2003020289A9 Treatment of dementia and memory disorders with anticonvulsants and acetylcholinesterase inhibitors
07/10/2003WO2003015872A3 Intravaginal administration of an aromatase inhibitor for the treatment of oestrogen-dependent proliferative disorders
07/10/2003WO2003010140A3 Hepatitis c virus polymerase inhibitors with heterobicyclic structure
07/10/2003WO2003008452A3 Bispecific monoclonal antibodies to il-12 and il-18 receptors
07/10/2003WO2003006440A8 Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound
07/10/2003WO2003004511A3 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals
07/10/2003WO2002090520A3 Toll/interleukin-1 receptor adaptor protein (tirap)
07/10/2003WO2002083060A3 Use of amino acid transporter atb0,+ as a delivery system for drugs and prodrugs
07/10/2003WO2002074956A3 Dopaminergic neuronal survival-promoting factors and uses thereof
07/10/2003WO2002063008A3 Intracellular signaling molecules
07/10/2003WO2002059267A3 Constitutively desensitized g protein-coupled receptors
07/10/2003WO2002046409A3 Proteins and nucleic acids encoding same
07/10/2003WO2002028408A9 Compositions and methods for the transport of biologically active agents across cellular barriers
07/10/2003WO2002013845A3 Inflammation related g-protein coupled receptor
07/10/2003WO2002009761A9 Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure
07/10/2003WO2002009675A9 Particulate composition of eletriptan showing a sigmoidal pattern of controlled release
07/10/2003WO2001098248A3 Hiv integrase inhibitors
07/10/2003WO2001096297A3 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
07/10/2003WO2001088096A3 Ovine tissue for xenotransplantation
07/10/2003US20030131380 Coffee mannanase
07/10/2003US20030131370 Disruption of the glutathione S-transferase-Omega-1 gene
07/10/2003US20030130626 Apparatus with weeping tip and method of use
07/10/2003US20030130517 Useful as antiinflammatory drugs, particularly as remedies for rheumatoid arthritis
07/10/2003US20030130515 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
07/10/2003US20030130508 3,5-bis(trifluoromethyl)phenylmethylene-substituted derivatives of nicotamide or pyridinylaminocarbonyl compounds; used to treat disorders of the central nervous system such as anxiety, depression and psychosis.
07/10/2003US20030130505 Nonsteroidal agonists and antagonists
07/10/2003US20030130486 A fusion proteins having the C-terminal region of the interfero protein is replaced by a C-terminal region of tau proteins; viricides, antiproliferation agents, antiinflammatory agents; lower cytotoxic side effects
07/10/2003US20030130355 Serotonin/noradrenaline reuptake inhibitors (N-(1-(1-(4-chlorophenyl)cyclobutyl)-3-methylbutyl)-N,N-dimethylamine; dietetics; side effects reduction
07/10/2003US20030130354 Such as 3,5-dimethyl-1-adamantanecarboximidamide hydrochloride; glutamate receptors; methyl-D-aspartate receptors; neurodegenerative diseases; side effect reduction
07/10/2003US20030130352 Such as 13,14-dihydro-15-keto-16,16-difluoro-prostaglandin E for treatment of cystic fibrosis
07/10/2003US20030130337 Indole derivatives as anti-inflammatory agents
07/10/2003US20030130335 Protein tyrosine phosphatases inhibitors
07/10/2003US20030130333 Combination product and methods of use
07/10/2003US20030130330 Materials and methods for the treatment of hypertension and angina
07/10/2003US20030130329 Imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
07/10/2003US20030130325 Substituted tryptophan derivatives
07/10/2003US20030130324 Method for preventing or controlling cataract
07/10/2003US20030130322 Biaryl ether derivative as opiod antagonist
07/10/2003US20030130320 Alpha 4 integrin antagonists
07/10/2003US20030130319 Aminopyrrole compounds
07/10/2003US20030130315 Administering a (R)-4-(1-hydroxy-4-(4-(hydroxydiphenyl methyl)-1-piperidinyl)butyl)-alpha,alpha-dimethyl-benzeneacetic acid derivative
07/10/2003US20030130305 Azabicyclic-phenyl-fused-heterocyclic compounds for treatment of disease
07/10/2003US20030130303 Pharmaceutical composition and method of treatment of diseases of cognitive dysfunction in a mammal
07/10/2003US20030130293 Detection defect in gene expression of hedgehog gene; diagnosis of cancer
07/10/2003US20030130292 Immunosuppressants; autoimmune disease; skin disorders; Crohn's disease; antidiabetic agents; anticancer agents; antiarthritic agents
07/10/2003US20030130289 Inhibitors of glycogen synthase kinase 3
07/10/2003US20030130286 Antiproliferative agents; anticancer agents; central nervous system disorders; antiarthritic agents
07/10/2003US20030130285 Controlling cell differentiation, cell proliferation
07/10/2003US20030130282 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
07/10/2003US20030130280 Analyzing, prevention blood phosphorylation
07/10/2003US20030130277 Pyrazoloquinolinone derivatives as protein kinase C inhibitors
07/10/2003US20030130276 Method of treating certain cancers using an estrogen agonist/antagonist
07/10/2003US20030130273 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
07/10/2003US20030130271 1,3-Diheterocyclic metalloprotease inhibitors
07/10/2003US20030130263 Mixture of two antihistamines; sustained release
07/10/2003US20030130261 Central nervous system disorders; psychological disorders; inflammatory bowel disorders
07/10/2003US20030130260 Aryl fused azapolycyclic compounds
07/10/2003US20030130254 Respiratory system disorders; antihistamines; antiarthritic agents
07/10/2003US20030130245 Stabilized aqueous suspensions for parenteral use
07/10/2003US20030130244 Mixture of estrogen, androgen and anticholinergic agent
07/10/2003US20030130242 Administering hypocalcemic hydroxyvitamin d compound having ahydrocarbon moiety at the c-24 position as anticarcinogenic agent
07/10/2003US20030130238 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors
07/10/2003US20030130237 Lysophosphatidic acid receptor antagonist; anticancer agents
07/10/2003US20030130236 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
07/10/2003US20030130235 3-[4-Substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2- indolinone derivatives as kinase inhibitors
07/10/2003US20030130225 Urogenital disorders; concurrent administering fluconazole by mouth and topical applying fungicide in situ
07/10/2003US20030130216 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease(cad) for treating cardiac disease
07/10/2003US20030130210 Method for treating a patient with neoplasia by treatment with an anthracycline antibiotic
07/10/2003US20030130209 Method of treatment of myocardial infarction
07/10/2003US20030130201 Mixture with ascorbic acid, proline and lysine
07/10/2003US20030130200 Tripeptide or tetrapeptide
07/10/2003US20030130193 Controlling cell proliferation, cell differentiation; immobilization
07/10/2003US20030130184 Using protein from papilloma virus; genetic engineering
07/10/2003US20030130168 Reverse-turn mimetics and methods relating thereto
07/10/2003US20030129706 Fhm, a novel member of the TNF ligand supergene family
07/10/2003US20030129697 Endothelial and Smooth muscle cell-Derived Neuropilin-like molecule; effective in restenosis after percutaneous transluminal coronany angioplasty and arterial sclerosis
07/10/2003US20030129688 Heregulin variants
1 ... 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 ... 1564